Expert Analysis Of Rater Discrepancies Allows Sponsor To Demonstrate Efficacy (Even With A Missing Endpoint)
Source: WCG

How did a small neuroscience pharmaceutical company uncover unexpected complications in the implementation and use of an assessment tool? Discover how the sponsor gained the confidence required to proceed with the development of their movement disorder compound.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more